XYL

SEC source: 0001562180-24-002291 · primarydocument.xml · derivative · entry 6

McShane Geri-Michelle · CIK 0001769064 · VP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,884

Underlying: Common Stock · 1,884 shares

Expires 2034-03-01

F6 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2025, March 1, 2026 and March 1, 2027.

SEC source: 0001562180-24-002291 · primarydocument.xml · nonDerivative · entry 5

McShane Geri-Michelle · CIK 0001769064 · VP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,048

F5 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2025, March 1, 2026 and March 1, 2027.

SEC source: 0001562180-24-002291 · primarydocument.xml · nonDerivative · entry 4

McShane Geri-Michelle · CIK 0001769064 · VP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,491

F4 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2021 (74), March 1, 2022 (87), and March 1, 2023 (82) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).

SEC source: 0001562180-24-002291 · primarydocument.xml · nonDerivative · entry 3

McShane Geri-Michelle · CIK 0001769064 · VP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,734

F3 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016).

SEC source: 0001562180-24-002291 · primarydocument.xml · nonDerivative · entry 2

McShane Geri-Michelle · CIK 0001769064 · VP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,250

F2 · shares: Reflects the acquisition of 501 shares of common stock earned upon vesting of performance-based restricted stock units granted on March 1, 2021 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return.

SEC source: 0001562180-24-002291 · primarydocument.xml · nonDerivative · entry 1

McShane Geri-Michelle · CIK 0001769064 · VP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,749

F1 · shares: Reflects the acquisition of 814 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ROIC.

SEC source: 0001562180-24-002290 · primarydocument.xml · derivative · entry 6

McGann Michael J. · CIK 0001962070 · SVP & President Americas & MCS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,619

Underlying: Common Stock · 5,619 shares

Expires 2034-03-01

F7 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2025, March 1, 2026 and March 1, 2027.

SEC source: 0001562180-24-002290 · primarydocument.xml · nonDerivative · entry 5

McGann Michael J. · CIK 0001962070 · SVP & President Americas & MCS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,681

F6 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2025, March 1, 2026 and March 1, 2027.

SEC source: 0001562180-24-002290 · primarydocument.xml · nonDerivative · entry 4

McGann Michael J. · CIK 0001962070 · SVP & President Americas & MCS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,020

F5 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2021 (90), March 1, 2022 (106), and March 1, 2023 (272) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).

SEC source: 0001562180-24-002290 · primarydocument.xml · nonDerivative · entry 3

McGann Michael J. · CIK 0001962070 · SVP & President Americas & MCS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,488

F4 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016).

SEC source: 0001562180-24-002290 · primarydocument.xml · nonDerivative · entry 2

McGann Michael J. · CIK 0001962070 · SVP & President Americas & MCS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,098

F3 · shares: Reflects the acquisition of 814 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ROIC.

SEC source: 0001562180-24-002290 · primarydocument.xml · nonDerivative · entry 1

McGann Michael J. · CIK 0001962070 · SVP & President Americas & MCS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,284

F1 · shares: Reflects the acquisition of 501 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return.

F2 · balance_after: Includes additional shares due to dividend reinvestment.

SEC source: 0001562180-24-002288 · primarydocument.xml · derivative · entry 3

Capers Dorothy Trefon · CIK 0001905353 · SVP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,792

Underlying: Common Stock · 4,792 shares

Expires 2034-03-01

F4 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2025, March 1, 2026 and March 1, 2027.

SEC source: 0001562180-24-002288 · primarydocument.xml · nonDerivative · entry 2

Capers Dorothy Trefon · CIK 0001905353 · SVP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,864

F3 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled which are scheduled to vest in one third increments on March 1, 2025, March 1, 2026 and March 1, 2027.

SEC source: 0001562180-24-002288 · primarydocument.xml · nonDerivative · entry 1

Capers Dorothy Trefon · CIK 0001905353 · SVP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,447

F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2022 (687) and March 1, 2023 (289) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).

F2 · balance_after: Includes additional shares due to dividend reinvestment.

SEC source: 0001562180-24-001593 · primarydocument.xml · nonDerivative · entry 1

McShane Geri-Michelle · CIK 0001769064 · VP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,935

F1 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 1,000 Shares were executed at a range of prices from $122.89 to $123.89. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

F2 · balance_after: Amount shown reflects additional shares acquired via a dividend reinvestment plan or DRIP.

SEC source: 0001562180-24-001391 · primarydocument.xml · nonDerivative · entry 1

Beliveau-Dunn Jeanne · CIK 0001714894 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,298

F1 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 1,835 Shares were executed at a range of prices from $124.4915 to $125.4914. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001562180-24-001390 · primarydocument.xml · derivative · entry 3

Aulick Rodney · CIK 0001720147 · SVP & President, WSS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,870

Underlying: Common Stock · 23,870 shares

Expires 2028-04-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The April 2, 2018 option grant vested one fourth on January 1, 2019, January 1, 2020, January 1, 2021, and January 1, 2022.

SEC source: 0001562180-24-001390 · primarydocument.xml · nonDerivative · entry 2

Aulick Rodney · CIK 0001720147 · SVP & President, WSS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,495

F1 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 23,870 Shares were executed at a range of prices from $122.45 to $123.4499. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001562180-24-001390 · primarydocument.xml · nonDerivative · entry 1

Aulick Rodney · CIK 0001720147 · SVP & President, WSS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 104,365

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001562180-24-001256 · primarydocument.xml · nonDerivative · entry 1

Cerwinka Franz · CIK 0001813828 · SVP & Pres, AWS & Bus Trnsform

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,750

F1 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 2,408 Shares were executed at a range of prices from $121.788 to $121.8019.The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

F2 · balance_after: Includes additional shares due to dividend reinvestment.

SEC source: 0001562180-24-001255 · primarydocument.xml · nonDerivative · entry 1

Toussaint Claudia S · CIK 0001421560 · SVP, CPSO

10b5-1 filing: No plan indicated

Ownership: Indirect · by Claudia S Toussaint Revocable Trust

Disclosed balance after: 31,431

F1 · shares: Reflects the sale of shares of common stock from the Claudia S. Toussaint Revocable Trust of which the reporting person is trustee. The reporting person and members of her immediate family are the sole beneficiaries of the trust.

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 9,028 Shares were executed at a range of prices from $122.21 to $122.27. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001562180-24-000096 · primarydocument.xml · nonDerivative · entry 4

Aulick Rodney · CIK 0001720147 · SVP & President, WSS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,495

F4 · shares: Reflects units withheld to pay the tax liability incident to the vesting of restricted stock units granted on February 16, 2021 under the Evoqua Water Technologies 2017 Equity Plan.

F5 · balance_after: Includes additional shares of earned but unvested PSUs which were converted to unvested RSUs at the time of acquisition on May 24, 2023.

SEC source: 0001562180-24-000096 · primarydocument.xml · nonDerivative · entry 3

Aulick Rodney · CIK 0001720147 · SVP & President, WSS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,967

F3 · shares: Reflects units withheld to pay the tax liability incident to the vesting of restricted stock units granted on December 31, 2021 under the Evoqua Water Technologies 2017 Equity Plan.

SEC source: 0001562180-24-000096 · primarydocument.xml · nonDerivative · entry 2

Aulick Rodney · CIK 0001720147 · SVP & President, WSS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,307

F2 · shares: Reflects units withheld to pay the tax liability incident to the vesting of restricted stock units granted on February 14, 2020 under the Evoqua Water Technologies 2017 Equity Plan.

SEC source: 0001562180-24-000096 · primarydocument.xml · nonDerivative · entry 1

Aulick Rodney · CIK 0001720147 · SVP & President, WSS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,703

F1 · shares: Reflects units withheld to pay the tax liability incident to the vesting of restricted stock units granted on December 9, 2022 under the Evoqua Water Technologies 2017 Equity Plan.

SEC source: 0001562180-23-008272 · primarydocument.xml · nonDerivative · entry 1

Harker Victoria D · CIK 0001350579 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,679

SEC source: 0001562180-23-007729 · primarydocument.xml · derivative · entry 4

Decker Patrick · CIK 0001403434 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 99,648 shares

Expires 2025-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The February 24, 2015 option grant vested one-third on February 24, 2016, February 24, 2017 and February 24, 2018.

SEC source: 0001562180-23-007729 · primarydocument.xml · nonDerivative · entry 3

Decker Patrick · CIK 0001403434 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 287,564

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 10, 2023.

F3 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). These Shares were executed at a range of prices from $101.04 to $101.30. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001562180-23-007729 · primarydocument.xml · nonDerivative · entry 2

Decker Patrick · CIK 0001403434 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 336,754

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 10, 2023.

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). These Shares were executed at a range of prices from $100.04 to $101.035. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001562180-23-007729 · primarydocument.xml · nonDerivative · entry 1

Decker Patrick · CIK 0001403434 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 387,212

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001562180-23-005790 · primarydocument.xml · derivative · entry 4

Decker Patrick · CIK 0001403434 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,648

Underlying: Common Stock · 99,649 shares

Expires 2025-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The February 24, 2015 option grant vested one-third on February 24, 2016, February 24, 2017 and February 24, 2018.

SEC source: 0001562180-23-005790 · primarydocument.xml · nonDerivative · entry 3

Decker Patrick · CIK 0001403434 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 287,564

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 10, 2023.

F3 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). These Shares were executed at a range of prices from $111.77 to $112.7699. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001562180-23-005790 · primarydocument.xml · nonDerivative · entry 2

Decker Patrick · CIK 0001403434 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 319,087

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 10, 2023.

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). These Shares were executed at a range of prices from $110.77 to $111.7699. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001562180-23-005790 · primarydocument.xml · nonDerivative · entry 1

Decker Patrick · CIK 0001403434 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 387,213

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001562180-23-005166 · primarydocument.xml · nonDerivative · entry 1

Cerwinka Franz · CIK 0001813828 · SVP & Pres, AWS & Bus Trnsform

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,107

F1 · shares: Reflects units withheld to pay the tax liability incident to the vesting of restricted stock units granted on June 12, 2020 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).

F2 · balance_after: Includes additional shares due to dividend reinvestment.

SEC source: 0001562180-23-004541 · primarydocument.xml · nonDerivative · entry 2

SWANN LYNN C · CIK 0001253486 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,630

F2 · shares: Received in exchange for 35,418 shares of Evoqua common stock in connection with the Merger. On May 24, 2023, the effective date of the Merger, the closing price of Evoqua's common stock was $49.88 per share, and the closing price of Xylem Inc.'s common stock was $101.06 per share.

SEC source: 0001562180-23-004541 · primarydocument.xml · nonDerivative · entry 1

SWANN LYNN C · CIK 0001253486 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,633

F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) and sub-pool of shares from the Evoqua Water Technologies 2017 Equity Plan assumed by Xylem Inc. as part of the merger of Xylem Inc. and Evoqua Water Technologies Corp. ("Evoqua") on May 24, 2023 (the "Merger"), that are scheduled to vest in full on the trading day prior to the 2024 Annual Meeting of Shareholders.

SEC source: 0001562180-23-004542 · primarydocument.xml · nonDerivative · entry 2

Glatch Lisa · CIK 0001339795 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,596

F2 · shares: Received in exchange for 12,427 shares of Evoqua common stock in connection with the Merger. On May 24, 2023, the effective date of the Merger, the closing price of Evoqua's common stock was $49.88 per share, and the closing price of Xylem Inc.'s common stock was $101.06 per share.

SEC source: 0001562180-23-004542 · primarydocument.xml · nonDerivative · entry 1

Glatch Lisa · CIK 0001339795 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,633

F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) and sub-pool of shares from the Evoqua Water Technologies 2017 Equity Plan assumed by Xylem Inc. as part of the merger of Xylem Inc. and Evoqua Water Technologies Corp. ("Evoqua") on May 24, 2023 (the "Merger"), that are scheduled to vest in full on the trading day prior to the 2024 Annual Meeting of Shareholders.

SEC source: 0001562180-23-004540 · primarydocument.xml · nonDerivative · entry 2

Aulick Rodney · CIK 0001720147 · SVP & President, IS&S

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,103

F2 · shares: Received in exchange for 130,589 shares of Evoqua common stock in connection with the Merger. On May 24, 2023, the effective date of the Merger, the closing price of Evoqua's common stock was $49.88 per share, and the closing price of Xylem Inc.'s common stock was $101.06 per share.

SEC source: 0001562180-23-004540 · primarydocument.xml · nonDerivative · entry 1

Aulick Rodney · CIK 0001720147 · SVP & President, IS&S

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,421

F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) and sub-pool of shares from the Evoqua Water Technologies 2017 Equity Plan assumed by Xylem Inc. as part of the merger of Xylem Inc. and Evoqua Water Technologies Corp. ("Evoqua") on May 24, 2023 (the "Merger"), that are scheduled to vest in two equal parts on May 24, 2024 and on May 24, 2025.

SEC source: 0001562180-23-004401 · primarydocument.xml · nonDerivative · entry 1

Tretikov Lila · CIK 0001620654 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,168

F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2024 Annual Meeting of Shareholders.

F2 · balance_after: Includes additional shares due to dividend reinvestment.

SEC source: 0001562180-23-004396 · primarydocument.xml · nonDerivative · entry 1

Peribere Jerome A · CIK 0001484527 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,392

F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2024 Annual Meeting of Shareholders. The Reporting Person has elected to defer the settlement of the RSU Award until Separation from Service

F2 · balance_after: Includes additional shares due to dividend reinvestment.

SEC source: 0001562180-23-004400 · primarydocument.xml · nonDerivative · entry 1

Yadav Uday · CIK 0001479938 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,137

F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2024 Annual Meeting of Shareholders.

F2 · balance_after: Includes additional shares due to dividend reinvestment.

F3 · balance_after: The reporting person's grant of 1,401 RSUs on August 11, 2020, reported on a Form 4 filed August 12, 2020, incorrectly contained a footnote referencing an election to defer settlement of the award. This footnote is included herewith to clarify that none of the beneficially owned shares reported are subject to deferral.

SEC source: 0001562180-23-004399 · primarydocument.xml · nonDerivative · entry 1

Morelli Mark D · CIK 0001411290 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,813

F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2024 Annual Meeting of Shareholders.

F2 · balance_after: Includes additional shares due to dividend reinvestment.

SEC source: 0001562180-23-004398 · primarydocument.xml · nonDerivative · entry 1

Harker Victoria D · CIK 0001350579 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,679

F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2024 Annual Meeting of Shareholders.

SEC source: 0001562180-23-004395 · primarydocument.xml · nonDerivative · entry 1

LORANGER STEVEN R · CIK 0001226924 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,818

F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2024 Annual Meeting of Shareholders. The Reporting Person has elected to defer the settlement of the RSU Award until Separation from Service

SEC source: 0001562180-23-004394 · primarydocument.xml · nonDerivative · entry 1

FRIEL ROBERT F · CIK 0001224110 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,017

F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2024 Annual Meeting of Shareholders. The Reporting Person has elected to defer the settlement of the RSU Award until Separation from Service

F2 · balance_after: Includes additional shares due to dividend reinvestment.

SEC source: 0001562180-23-004397 · primarydocument.xml · nonDerivative · entry 1

ELLIS EARL RAY · CIK 0001835584 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,829

F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2024 Annual Meeting of Shareholders.